Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

WEST STAR LABS LLC

NPI: 1801513338 · EL PASO, TX 79902 · Clinical Medical Laboratory · NPI assigned 10/25/2022

$9K
Total Medicaid Paid
527
Total Claims
513
Beneficiaries
3
Codes Billed
2022-11
First Month
2023-09
Last Month

Provider Details

Authorized OfficialRAMOS, CARLOS (OWNER)
NPI Enumeration Date10/25/2022

Related Entities

Other providers sharing the same authorized official: RAMOS, CARLOS

ProviderCityStateTotal Paid
LUNAMED AMBULANCE SERVICES, INC. CAGUAS PR $490K
CARLOS RAMOS MD PA MIAMI FL $78K
CONSULTORIO DE MEDICINA INTERNA CSP SAN SEBASTIAN PR $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 79 $50.46
2023 448 $9K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 153 146 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 360 353 $4K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 14 14 $2.20